NovoCure Limited (NVCR)

NovoCure Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	185.42	240.82	115.33	208.8	234.67	177.32
Short-Term Investments	774.48	669.8	854.1	728.9	607.9	148.77
Cash & Short-Term Investments	959.9	910.62	969.43	937.7	842.58	326.09
Cash Growth	4.20%	-6.07%	3.38%	11.29%	158.39%	32.62%
Accounts Receivable	67.06	61.22	86.26	93.57	96.7	58.86
Other Receivables	25.44	5.26	12.39	8.42	13.36	21.38
Receivables	92.5	66.48	98.65	101.99	110.06	80.24
Inventory	39.1	38.15	29.38	24.43	27.42	23.7
Prepaid Expenses	-	6.85	6.42	4.76	4.12	2.72
Restricted Cash	3.78	1.74	0.51	0.81	11.5	2.1
Other Current Assets	-	10.56	7.15	3.84	3.77	5.1
Total Current Assets	1,095	1,034	1,112	1,074	999.44	439.95
Property, Plant & Equipment	114.49	97.7	68.96	53.88	41.63	34.6
Other Long-Term Assets	12.22	14.02	11.16	12.09	10.91	4.9
Total Assets	1,222	1,146	1,192	1,139	1,052	479.45
Accounts Payable	91.32	94.39	85.2	72.6	53.65	36.93
Accrued Expenses	-	60.18	49.44	45.39	35.66	32.92
Current Portion of Leases	-	8.22	-	-	-	-
Current Unearned Revenue	-	16.22	18.03	17.76	17.77	11.77
Other Current Liabilities	86.35	0.1	6.11	6.85	6.54	4.7
Total Current Liabilities	735	179.12	158.78	142.6	113.61	86.31
Long-Term Debt	97.15	568.82	565.58	562.23	429.95	149.49
Long-Term Leases	21.14	27.42	18.76	13	14.29	14.14
Long-Term Unearned Revenue	-	-	2.88	6.48	12.14	7.81
Other Long-Term Liabilities	0.02	0.02	0.08	0.15	0.3	0.16
Total Liabilities	861.21	783.63	750.48	729	575.46	261.66
Additional Paid-In Capital	1,454	1,353	1,222	1,100	1,111	871.44
Retained Earnings	-1,088	-985.5	-778.46	-685.93	-631.08	-650.89
Comprehensive Income & Other	-5.38	-5.47	-2.43	-3.17	-3.83	-2.77
Shareholders' Equity	360.78	362.5	441.17	410.49	476.53	217.79
Total Liabilities & Equity	1,222	1,146	1,192	1,139	1,052	479.45
Total Debt	675.63	604.47	584.34	575.23	444.24	163.63
Net Cash (Debt)	284.27	306.15	385.08	362.48	398.34	162.46
Net Cash Growth	-14.17%	-20.50%	6.24%	-9.00%	145.19%	68.32%
Net Cash Per Share	2.64	2.88	3.68	3.50	3.66	1.67
Filing Date Shares Outstanding	108.2	107.09	105.46	104.42	102.41	99.64
Total Common Shares Outstanding	108.1	107.08	105.05	103.97	102.33	99.53
Working Capital	360.27	855.29	952.75	930.92	885.83	353.64
Book Value Per Share	3.34	3.39	4.20	3.95	4.66	2.19
Tangible Book Value	360.78	362.5	441.17	410.49	476.53	217.79
Tangible Book Value Per Share	3.34	3.39	4.20	3.95	4.66	2.19
Land	-	24.7	15.99	11.16	-	-
Machinery	-	43.05	30.94	26.56	23.32	19.17
Leasehold Improvements	-	11.7	9.35	7.08	6.5	4.82

Source: S&P Capital IQ. Standard template. Financial Sources.